PeptidXs

Welcome to PeptidXs

You must be at least 21 years old to visit this site.

Disclaimer

All products sold by PeptidXs are strictly intended for laboratory research use only. They are not approved for human or animal consumption, or for any form of therapeutic or diagnostic use.

We do not provide usage instructions, dosing guidelines, or any advice regarding the application of our products.

PeptidXs is a research supply company only.

By entering this site, you are accepting our Terms of Service.

Back to Research Library
CJC-1295 & Ipamorelin: Growth Hormone Secretagogues Explained
education 7 min readCJC-1295IpamorelinGrowth HormoneGHRH

CJC-1295 & Ipamorelin: Growth Hormone Secretagogues Explained

CJC-1295 and Ipamorelin are often studied in combination for their synergistic effects on growth hormone release. This article covers the science of GHRH analogs and ghrelin mimetics in research settings.

Introduction to Growth Hormone Secretagogues

Growth hormone secretagogues (GHS) are compounds that stimulate the secretion of growth hormone (GH) from the pituitary gland. Unlike direct GH administration, GHS compounds work through endogenous pathways, either mimicking GHRH or ghrelin signaling.

CJC-1295: A GHRH Analog

CJC-1295 is a synthetic analog of growth hormone-releasing hormone (GHRH). The DAC (Drug Affinity Complex) version binds to albumin in the bloodstream, extending its half-life from minutes to approximately 6-8 days.

Mechanism

  • Binds GHRH receptors on anterior pituitary somatotrophs
  • Stimulates GH release in pulsatile fashion
  • Elevates IGF-1 levels in preclinical studies

Ipamorelin: A Selective Ghrelin Mimetic

Ipamorelin is a pentapeptide GHS-R (ghrelin receptor) agonist. It is notable for its selectivity — stimulating GH release with minimal effect on cortisol, prolactin, or ACTH, which are commonly elevated by other GH secretagogues.

Why Combine Them?

CJC-1295 and Ipamorelin act on complementary pathways (GHRH receptor vs. ghrelin receptor), and preclinical research suggests their combination produces a synergistic increase in GH pulse amplitude without disrupting normal pulsatility.

Research Applications

  • Age-related GH decline models
  • Body composition studies in rodents
  • Sleep quality and slow-wave sleep research (GH is primarily secreted during deep sleep)
  • Recovery and anabolic signaling pathways

Important Notes

All applications are strictly preclinical. GH secretagogue research requires careful controls, particularly around IGF-1 measurement and pulsatility assessment. Researchers should be aware that GHS compounds are on the WADA prohibited list.

Conclusion

CJC-1295 and Ipamorelin represent well-characterized research tools for studying the GH/IGF-1 axis with a favorable selectivity profile compared to older secretagogues.

Research Disclaimer

This article is intended for educational and research purposes only. All products referenced are for laboratory research use only and are not approved for human or animal consumption. PeptidXs does not provide medical advice.

PeptidXs

Trusted premium research peptides. 99%+ purity guaranteed, third-party tested, with Certificate of Analysis included with every order.

FDA DisclaimerPeptidXs products are intended strictly for laboratory and research purposes only. None of our products have been evaluated or approved by the U.S. Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease or medical condition. Nothing on this website constitutes medical advice or replaces guidance from a licensed healthcare professional. If you have questions about a health condition or medication, consult a qualified provider before proceeding. Use of our products is subject to all applicable federal, state, and local regulations. Read full disclaimer →

© 2026 PeptidXs. All rights reserved. For research use only.